Viewing StudyNCT00346281



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00346281
Status: UNKNOWN
Last Update Posted: 2006-06-29
First Post: 2006-06-27

Brief Title: 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer
Sponsor: pSiMedica Limited
Organization: pSiMedica Limited

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
unresectable View
unresectable pancreatic cancer View
brachytherapy View
32P View
BioSilicon View
locally advanced View
gemcitabine View
intratumourally View